Clarification of NIH Policy on Post-Submission Application Materials for PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)"
(NOT-HD-16-015) Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3)
(RFA-DK-16-007)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s):
November 14, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)
(RFA-HL-17-015)
National Heart, Lung, and Blood Institute
Application Receipt Date(s):
October 13, 2016; January 10, 2017; May 10, 2017; October 13, 2017; January 10, 2018; May 10, 2018; October 10, 2018; January 10, 2019; May 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
(PA-16-332)
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Complementary and Integrative Health
National Cancer Institute
Office of Dietary Supplements
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
(PAR-16-322)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Advancing Basic Behavioral and Social Research on Resilience: An Integrative Science Approach (UG3/UH3)
(PAR-16-326)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Mental Health
Application Receipt Date(s):
December 1, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)
(PAR-16-329)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Environmental Health Sciences
Application Receipt Date(s):
September 13, 2016; September 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
(PAR-16-330)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Environmental Health Sciences
Application Receipt Date(s):
September 13, 2016; September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
(PAR-16-331)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Environmental Health Sciences
Application Receipt Date(s):
September 13, 2016; September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21)
(PAR-16-336)
National Cancer Institute
Application Receipt Date(s):
Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)
(PAR-16-337)
National Cancer Institute
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)
(PAR-16-338)
National Cancer Institute
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.